Search Results - "Husereau, D"

Consolidated Health Economic Evaluation Reporting Standards (CHEERS) statement by Husereau, Don, Drummond, Michael, Petrou, Stavros, Carswell, Chris, Moher, David, Greenberg, Dan, Augustovski, Federico, Briggs, Andrew H, Mauskopf, Josephine, Loder, Elizabeth

“…Economic evaluations of health interventions pose a particular challenge for reporting. There is also a need to consolidate and update existing guidelines and…”
Get full text

Consolidated Health Economic Evaluation Reporting Standards 2022 (CHEERS 2022) statement: updated reporting guidance for health economic evaluations by Husereau, D, Drummond, M, Augustovski, F, Briggs, AH, Carswell, C, Caulley, L, Chaiyakunapruk, N, Bekker‐Grob, E, Greenberg, D, Loder, E, Mauskopf, J, Mullins, CD, Petrou, S, Pwu, R‐F, Staniszewska, S

“…Health economic evaluations are comparative analyses of alternative courses of action in terms of their costs and consequences. The Consolidated Health…”
Get full text

Improving the reporting of economic evaluation in osteoporosis: the value of CHEERS 2022 statement by Hiligsmann, M., Li, N., Cooper, C., Reginster, J.-Y., Silverman, S., Carswell, C., Husereau, D.

Get full text

Efficacy of statins for primary prevention in people at low cardiovascular risk: a meta-analysis by Tonelli, Marcello, Lloyd, Anita, Clement, Fiona, Conly, Jon, Husereau, Don, Hemmelgarn, Brenda, Klarenbach, Scott, McAlister, Finlay A, Wiebe, Natasha, Manns, Braden

“…Statins were initially used to improve cardiovascular outcomes in people with established coronary artery disease, but recently their use has become more…”
Get full text

Consolidated Health Economic Evaluation Reporting Standards (CHEERS) statement by Husereau, D, Drummond, M, Petrou, S, Carswell, C, Moher, D, Greenberg, D, Augustovski, F, Briggs, AH, Mauskopf, J, Loder, E

“…Economic evaluations of health interventions pose a particular challenge for reporting. There is also a need to consolidate and update existing guidelines and…”
Get full text

HTA40 Challenges in Evaluating and Paying for Combination Therapies in Oncology - a Canadian Perspective by Rogoza, RM, Husereau, D, Millson, B

Get full text

PPM4 Health and Budget IMPACT of Liquid-Based Comprehensive Genomic Profile Testing (CGP) in Advance NON-SMALL CELL LUNG Cancer (ANSCLC) Patients with Insufficient Tissue, Exhausted Tissue Samples and or Insufficient DNA in Tissue Samples by Patel, Y., Husereau, D., Leighl, N.B., Melosky, B., Nam, J.

Get full text

Early Scientific Advice At Cadth – Options and Recommendations For Future Development by Husereau, D, Sood, AR

“…OBJECTIVES: : Early Scientific Advice at CADTH was developed in response to a perceived need by innovators and modeled after similar programs internationally…”
Get full text

PHP244 - Early Scientific Advice At Cadth – Options and Recommendations For Future Development by Husereau, D, Sood, AR

Get full text

P22 Value of Information - Consolidated Health Economic Evaluation Reporting Standards: A Checklist Extension by Siu, A, Kunst, N, Drummond, M, Grimm, S, Grutters, J, Husereau, D, Koffijberg, H, Rothery, C, Wilson, E, Heath, A

Get full text

PNS18 IMPROVING THE APPLICATION OF PUBLISHED HEALTH UTILITIES IN COST-UTILITY ANALYSES: DEVELOPMENT OF THE HEALTH UTILITY APPLICATION TOOL (HAT) by Zoratti, M., Chan, K., Levine, O., Krahn, M., Husereau, D., Clifford, T., Schunemann, H., Guyatt, G., Xie, F.

Get full text

A35 SEVERE ASTHMA: Severe Asthma In Primary Care In Canada: A Longitudinal Study Of The Clinical Burden And Economic Impact Based On Linked Electronic Medical Record Data by Husereau, D, Goodfield, J, Leigh, R, Borrelli, R, Cloutier, M, Gendron, A, Marvin, D

“…Patients aged >12 years with two or more documented asthma diagnoses in the EMR database during the study period were identified as having severe asthma based…”
Get full text

A Guide to Selecting Flexible Survival Models to Inform Economic Evaluations of Cancer Immunotherapies by Palmer, Stephen, Borget, Isabelle, Friede, Tim, Husereau, Don, Karnon, Jonathan, Kearns, Ben, Medin, Emma, Peterse, Elisabeth F.P., Klijn, Sven L., Verburg-Baltussen, Elisabeth J.M., Fenwick, Elisabeth, Borrill, John

“…Parametric models are routinely used to estimate the benefit of cancer drugs beyond trial follow-up. The advent of immune checkpoint inhibitors has challenged…”
Get full text

PCN42 THE HEALTH UTILITY BOOK (HUB): TOWARD A CENTRALIZED, SYSTEMATIC APPROACH TO THE IDENTIFICATION, APPRAISAL, AND USE OF HEALTH STATE UTILITY VALUES FOR REIMBURSEMENT DECISION MAKING by Xie, F., Zoratti, M., Chan, K., Husereau, D., Krahn, M., Levine, O., Clifford, T., Schunemann, H., Guyatt, G.

Get full text

PCN41 THE HEALTH UTILITY BOOK (HUB): A REGISTRY OF HEALTH STATE UTILITY VALUES IN ONCOLOGY by Zoratti, M., Zhou, T., Chan, K., Levine, O., Krahn, M., Husereau, D., Clifford, T., Schunemann, H., Guyatt, G., Xie, F.

Get full text

PHP141 - Comparison of current and preferred status of hta implementation in central and eastern europen countries by Kalo, Z, Csanadi, M, Vitezic, D, Huic, M, Husereau, D, Kristensen, FB

Get full text

A general affinity method to purify peroxidase-tagged antibodies by Husereau, Donald R, Suresh, Mavanur R

“…Antibodies tagged with enzymes, e.g. horseradish peroxidase (HRPO) are used extensively in a broad range of immunoassay, immunohistochemical, and prodrug-based…”
Get full text

Comparison of current and preferred status of hta implementation in central and eastern europen countries by Kalo, Z, Csanadi, M, Vitezic, D, Huic, M, Husereau, D, Kristensen, FB

Get full text

Cost-effectiveness of the use of low- and high-potency statins in people at low cardiovascular risk by Conly, Jon, Clement, Fiona, Tonelli, Marcello, Hemmelgarn, Brenda, Klarenbach, Scott, Lloyd, Anita, McAlister, Finlay A, Husereau, Don, Wiebe, Natasha, Au, Flora, Manns, Braden

“…Although statins have been shown to reduce the risk of cardiovascular events in patients at low cardiovascular risk, their absolute benefit is small in the…”
Get full text

Systematic review and network meta-analysis of stroke prevention treatments in patients with atrial fibrillation by Tawfik A, Bielecki JM, Krahn M, Dorian P, Hoch JS, Boon H, Husereau D, Pechlivanoglou P

“…Amy Tawfik,1,2 Joanna M Bielecki,2 Murray Krahn,1,2 Paul Dorian,3,4 Jeffrey S Hoch,1,3,5 Heather Boon,1 Don Husereau,6 Petros Pechlivanoglou2 1Department of…”
Get full text